Luc Xerri

19.3k citations

172 papers · 9.0k indexed · 2 hit papers · h-index 45

Impact in

Pathology and Forensic Medicine top 0.1%
- Lymphoma Diagnosis and Treatment
Oncology top 0.5%
- Cancer Cells and Metastasis
- Viral-associated cancers and disorders
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research

Papers in

Pathology and Forensic Medicine 85
- Lymphoma Diagnosis and Treatment 76
Oncology 81
- Viral-associated cancers and disorders 35
- Cancer Immunotherapy and Biomarkers 11
- CAR-T cell therapy research 11

Co-authors: Daniel Birnbaum François Bertucci Emmanuelle Charafe‐Jauffret J Hassoun Christophe Ginestier Nathalie Cervera Pascal Finetti Jocelyne Jacquemier
Journals: Blood (20 papers)Journal of Clinical Oncology (10 papers)British Journal of Haematology (7 papers)Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (7 papers)Human Pathology (7 papers)
Partner nations: France United States Belgium

In The Last Decade

Luc Xerri

168 papers receiving 8.8k citations

Hit Papers

align trajectories log scale

Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer 2009 · 575 citations

Peers

Countries citing papers authored by Luc Xerri

Since Specialization

Citations

This map shows the geographic impact of Luc Xerri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luc Xerri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luc Xerri more than expected).

Fields of papers citing papers by Luc Xerri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luc Xerri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luc Xerri. The network helps show where Luc Xerri may publish in the future.

Co-authors

The 25 scholars most cited alongside Luc Xerri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Luc Xerri Line = papers co-authored together Luc Xerri links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Identification of an activated/memory B‐cell signature of poor outcome and sensitivity to lenalidomide in follicular lymphoma patients Hematological Oncology ·Camille Laurent, Preeti Trisal, Bruno Tesson, Bastien Lesne, null Vanacker, Loïc Chartier, Matthew P. Stokes, Christine Huang, Sarah Huet, Franck Morschhauser, Anita K. Gandhi, Luc Xerri	2023	1
2	Cutaneous presentation of enteropathy-associated T-cell lymphoma masquerading as a DUSP22-rearranged CD30+ lymphoproliferation Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Bettina Bisig, Anne Cairoli, Olivier Gaide, Joan Somja, Cloé Bregnard, Philippe Gaulard, Luc Xerri, Karine Lefort, Edoardo Missiaglia, Michel Gilliet, Daniel Hohl, Emmanuella Guenova, Laurence de Leval	2022	2
3	EZH2 alterations in follicular lymphoma: biological and clinical correlations Blood Cancer Journal ·Sarah Huet, Luc Xerri, Bruno Tesson, Sylvain Mareschal, Sébastien Taix, Lénaïg Mescam-Mancini, Emilie Sohier, Marjorie Carrère, Julien Lazarovici, Olivier Casasnovas, Laurie Tonon, Sandrine Boyault, Sandrine Hayette, Corinne Haïoun, Bettina Fabiani, Alain Viari, Fabrice Jardin, Gilles Salles	2017	55
4	Follicular B Lymphomas Generate Regulatory T Cells via the ICOS/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS/ICOSL Therapy Cancer Research ·Kieu-Suong Le, Marie‐Laure Thibult, Sylvain Just-Landi, Sonia Pastor, Françoise Gondois‐Rey, Samuel Granjeaud, Florence Broussais, Réda Bouabdallah, Renaud Colisson, Christophe Caux, Christine Ménétrier‐Caux, Dominique Leroux, Luc Xerri, Daniel Olive	2016	58
5	Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Leticia Quintanilla-Martı́nez, Birgitta Sander, John K. C. Chan, Luc Xerri, German Ott, Elı́as Campo, Steven H. Swerdlow	2015	53
6	Impact of induction chemotherapy regimen on response, safety and outcome in the PRIMA study Ghent University Academic Bibliography (Ghent University) ·Franck Morschhauser, J.F. Seymour, Pierre Feugier, Fritz Offner, Armando López‐Guillermo, R Bouabdallah, Lone Bredo Pedersen, Pauline Brice, David Belada, Luc Xerri, Gilles Salles	2011	12
7	Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature Cancer Research ·Emmanuelle Charafe‐Jauffret, Christophe Ginestier, Flora Iovino, Julien Wicinski, Nathalie Cervera, Pascal Finetti, Min-Hee Hur, Mark E. Diebel, Florence Monville, Julie Dutcher, Marty Brown, Patrice Viens, Luc Xerri, François Bertucci, Giorgio Stassi, Gabriela Dontu, Daniel Birnbaum, Max S. Wicha Hit paper breakdown →	2009	935
8	Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer Clinical Cancer Research ·Emmanuelle Charafe‐Jauffret, Christophe Ginestier, Flora Iovino, Carole Tarpin, Mark E. Diebel, Benjamin Esterni, Gilles Houvenaeghel, Jean-Marc Extra, François Bertucci, Jocelyne Jacquemier, Luc Xerri, Gabriela Dontu, Giorgio Stassi, Yi Xiao, Sanford H. Barsky, Daniel Birnbaum, Patrice Viens, Max S. Wicha Hit paper breakdown →	2009	575
9	Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer Breast Cancer Research ·Jocelyne Jacquemier, Emmanuelle Charafe‐Jauffret, Florence Monville, Benjamin Esterni, Jean Marc Extra, Gilles Houvenaeghel, Luc Xerri, François Bertucci, Daniel Birnbaum	2009	69
10	Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study Blood ·Gilles Salles, Nicolas Mounier, Sophie de Guibert, Franck Morschhauser, Chantal Doyen, Jean‐François Rossi, Corinne Haïoun, Pauline Brice, Beatrice Mahé, Réda Bouabdallah, B. Audhuy, Christophe Fermé, Caroline Dartigeas, Pierre Feugier, Catherine Sebban, Luc Xerri, Charles Foussard	2008	239
11	Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: Prominent expression of P-cadherin BMC Cancer ·Azza Ben Hamida, Intidhar S Labidi, Karima Mrad, Emmanuelle Charafe‐Jauffret, Saïda Ben Arab, Benjamin Esterni, Luc Xerri, Patrice Viens, François Bertucci, Daniel Birnbaum, Jocelyne Jacquemier	2008	28
12	Comparison of a Selection of Rapid Automated DNA and RNA Extraction Technologies for Detection of Somatic or Constitutional Gene Abnormalities in Cancer Diagnosis François Lassailly, Julien Mozziconacci, Tetsuro Noguchi, Didier Bechlian, José Adélaı̈de, Fréderic Fina, Pierre‐Marie Martin, Hagay Sobol, Luc Xerri, Daniel Birnbaum, Christian Chabannon	2007	3
13	ALDEFLUOR-positive populations in breast cell lines: evidence for cancer stem cells properties and gene expression profile (GEP) Cancer Research ·Emmanuelle Charafe‐Jauffret, Christophe Ginestier, Min Hee Hur, Florence Monville, Nathalie Cervera, Pascal Finetti, Julie Dutcher, Julien Wicinsky, M. M. Brown, Luc Xerri, François Bertucci, Daniel Birnbaum, Gabriela Dontu, Max S. Wicha	2007	1
14	Inflammatory breast cancers in Tunisia and France show similar immunophenotypes The Breast ·Emmanuelle Charafe‐Jauffret, Karima Mrad, Sana Intidhar Labidi‐Galy, Azza Ben Hamida, Khaled Ben Romdhane, Mansour Ben Abdallah, Christophe Ginestier, Benjamin Esterni, Daniel Birnbaum, Farhat Ben Ayed, Luc Xerri, Patrice Viens, Amel Mézlini, Jocelyne Jacquemier	2007	15
15	Prognosis and Gene Expression Profiling of 20q13-Amplified Breast Cancers Clinical Cancer Research ·Christophe Ginestier, Nathalie Cervera, Pascal Finetti, Séverine Esteyriès, Benjamin Esterni, José Adélaı̈de, Luc Xerri, Patrice Viens, Jocelyne Jacquemier, Emmanuelle Charafe‐Jauffret, Max Chaffanet, Daniel Birnbaum, François Bertucci	2006	107
16	FGFR1 and WT1 are markers of human prostate cancer progression BMC Cancer ·Elizabeth Devilard, Franck Bladou, Olivier Ramuz, G. Karsenty, Jean-Philippe Dalès, Gwénaëlle Gravis, Catherine Nguyen, François Bertucci, Luc Xerri, Daniel Birnbaum	2006	32
17	Analyse par « biopuces » du profil d’expression des gènes régulateurs de l’apoptose des lymphomes malins Bulletin de l Académie Nationale de Médecine ·Luc Xerri, Jean-Philippe Dalès, Élisabeth Devilard, J Hassoun, Françoise Birg	2001	0
18	Expression of the p53 gene in Hodgkin's disease: Dissociation between immunohistochemistry and clinicopathological data Human Pathology ·Luc Xerri, Réda Bouabdallah, Jacques Camerlo, J Hassoun	1994	26
19	An exceptional 18-year follow-up after cardiac transplantation. How can malignancies occur during immunosuppressive therapy? Cancer ·Luc Xerri, Marie-José Payan, Régine Choux, Nicole Gros, J Hassoun, A Chamlian, Dominique Blin, J R Montiès	1990	10
20	Type IV collagen immunostaining and computerized image analysis (SAMBA) in breast and endometrial disorders Histopathology ·Colette Charpin, L Andrac, B Devictor, M C Habib, H Vacheret, Luc Xerri, M N Lavaut, M Toga	1989	11

About Luc Xerri

Luc Xerri is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Immunology and Dermatology, having authored 172 papers that have together received 9.0k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (76 papers), Viral-associated cancers and disorders (35 papers), Chronic Lymphocytic Leukemia Research (29 papers), Immune Cell Function and Interaction (21 papers), T-cell and B-cell Immunology (13 papers), Cancer Immunotherapy and Biomarkers (11 papers), CAR-T cell therapy research (11 papers) and Immunotherapy and Immune Responses (9 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.4k citations), Oncology (4.6k citations), Genetics (1.3k citations), Immunology (2.4k citations) and Cancer Research (1.5k citations). Luc Xerri has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Daniel Birnbaum, François Bertucci, Emmanuelle Charafe‐Jauffret, J Hassoun, Christophe Ginestier, Nathalie Cervera, Pascal Finetti, Jocelyne Jacquemier, Élisabeth Devilard and Patrice Viens. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin and Human Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact